|Podcasts|January 25, 2022
Oncologists’ Insights on Clinical Trials
Author(s)Lisa Henderson, Andy Studna, Senior Editor
Dr. C.K. Wang, Chief Medical Officer for COTA discusses the use of real world data, the results of a recent survey by COTA, and his own career journey.
Dr. C.K. Wang, Chief Medical Officer for COTA discusses the use of real world data, the results of a recent survey by COTA, and his own career journey.
Read the study results discussed, here:
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
Future-Proofing Clinical Trial Supply Chains Against Tariff Risks
2
Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor
3
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
4
After the Trial is too Late: The Case for More Active Use of Patient-Reported Outcomes in Oncology Studies
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
